Premium
Update on human papillomavirus vaccines
Author(s) -
Fiander Alison
Publication year - 2006
Publication title -
the obstetrician and gynaecologist
Language(s) - English
Resource type - Journals
eISSN - 1744-4667
pISSN - 1467-2561
DOI - 10.1576/toag.8.2.113.27231
Subject(s) - vaccination , medicine , hpv vaccines , human papilloma virus , psychosocial , intraepithelial neoplasia , human papillomavirus , virology , virus , immunology , intensive care medicine , hpv infection , cervical cancer , cancer , psychiatry , prostate
While progress has been slow in the field of therapeutic vaccination, the subject of prophylactic vaccination has hit the headlines and generated much interest. Results from trials of prophylactic vaccination are exciting and demonstrate that virus‐like particle vaccines are safe, immunogenic and effective at protecting against persistent human papilloma virus infection and intraepithelial neoplasia. However, a number of important and complex issues need to be addressed for successful implementation, including scientific, economic, epidemiological and psychosocial considerations.